《全日總結》恆指跌83點 騰訊下滑逾2% 醫藥及內房股捱沽
阿思達克 01-19 16:31
港股今日(19日)先升後跌，恆指高開12點後，一度升148點曾高見15,540點，其後倒跌，午後曾跌183點低見15,207點，全日收報15,308點，跌83點或0.5%；國指跌44點或0.9%，收報5,127點；恆生科技指數亦跌46點或1.5%，收報3,129點。大市全日成交總額968.72億元，滬、深港通南下交易全日淨流入18.33億及5.38億元人民幣。
科技股普遍下跌，騰訊(00700.HK)跌2.3%收報271.2元，野村下調騰訊目標價至400元，維持「買入」評級。阿里(09988.HK)跌1.7%。嗶哩嗶哩(09626.HK)跌3.8%。萬國數據(09698.HK)及微盟(02013.HK)各跌8.8%及6.9%。金山雲(03896.HK)跌2.8%。
據報美團(03690.HK)前高級副總裁郭慶加盟京東(09618.HK)，或接管達達集團(DADA.US)，美團及京東各跌1.6%及2.5%。市傳快手(01024.HK)內測AIGC方案，招募達人測試AI一鍵生成視頻功能，快手收跌3.5%。網易(09999.HK)據報撤回對暴雪軟體著作權案訴訟，股價升1.3%。
乘聯會料本月新能源汽車零售量按月減少15.3%，電動車股零跑(09863.HK)跌4.8%。小鵬(09868.HK)跌4%。蔚來(09866.HK)及理想(02015.HK)各跌2.7%及2.8%。比亞迪(01211.HK)跌0.4%。至於吉利(00175.HK)則升0.4%。
內房股旭輝(00884.HK)跌6.2%。融創中國(01918.HK)及雅居樂(03383.HK)跌逾4%。綠城中國(03900.HK)跌3.9%。碧桂園(02007.HK)確認正洽售澳洲項目，料上半年可完成交易，該股平收報0.66元，同系碧服(06098.HK)則跌3.2%。
醫藥股受壓，信達生物(01801.HK)跌8.9%。翰森製藥(03692.HK)跌3.9%。中生製藥(01177.HK)及石藥(01093.HK)分別跌3.6%及近3%。
國家能源局指去年全社會用電量按年增6.7%，惟電力股華電國際(01071.HK)跌5.4%，潤電(00836.HK)、華能國電(00902.HK)及龍源(00916.HK)跌1.4%至3.3%。
重磅金融股匯控(00005.HK)升0.2%。港交所(00388.HK)跌1%。友邦(01299.HK)升2%。此外，中寶新材(02439.HK)尾市沽壓驟增，全日下瀉64%收報0.97元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
More Content
CS Hotline: +852 3018 4526
Trading days: 24 hours | Non-trading days: 9:00-18:00
